Bharat parenterals Financial Statements

Ratio Analysis

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth (10) 67.10 22.60 (6.90)
Op profit growth (10) 128 88.90 (37)
EBIT growth (17) 145 63.80 (23)
Net profit growth (16) 165 32.20 6.83
Profitability ratios (%)        
OPM 12.30 12.30 9 5.84
EBIT margin 13.60 14.80 10.10 7.52
Net profit margin 9.96 10.60 6.67 6.19
RoCE 19.90 33.10 18.10 11.40
RoNW 3.89 6.32 3.34 2.86
RoA 3.64 5.93 3 2.35
Per share ratios ()        
EPS 35.50 42.10 15.90 12
Dividend per share -- -- -- --
Cash EPS 25.10 31.90 6.18 1.93
Book value per share 251 206 127 111
Valuation ratios        
P/E 9.45 3.36 12.80 --
P/CEPS 13.40 4.45 32.90 --
P/B 1.33 0.69 1.60 --
EV/EBIDTA 5.95 1.82 6.28 --
Payout (%)        
Dividend payout -- -- -- --
Tax payout (25) (26) (29) (7.80)
Liquidity ratios        
Debtor days 131 110 137 144
Inventory days 45.70 34.60 39.70 48.10
Creditor days (70) (63) (92) (131)
Leverage ratios        
Interest coverage (36) (39) (15) (9.30)
Net debt / equity 0.07 (0.10) 0.06 0.08
Net debt / op. profit 0.39 (0.30) 0.38 0.74
Cost breakup ()        
Material costs (66) (65) (65) (71)
Employee costs (7.20) (6.80) (9.50) (10)
Other costs (15) (16) (17) (13)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

Open Demat Account
  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity